Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Isis Pharmaceuticals Inc (NASDAQ:ISIS)

53.05
Delayed Data
As of Jul 29
 -1.35 / -2.48%
Today’s Change
29.17
Today|||52-Week Range
77.80
-14.08%
Year-to-Date

Today’s Trading

Previous close54.40
Today’s open54.66
Day’s range52.22 - 54.88
Volume1,854,742
Average volume (3 months)2,369,304
Market cap$6.5B
Dividend yield--
Data as of 3:59pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)+28.18%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+45.41%
P/E ratioNM
Price/Sales33.93
Price/Book25.00

Competitors

 Today’s
change
Today’s
% change
ICLRICON PLC+3.38+4.49%
PRXLPAREXEL Internationa...+0.82+1.20%
DYAXDyax Corp-0.81-3.23%
CRLCharles River Labora...+0.17+0.22%
Data as of 4:05pm ET, 07/29/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)$0.39
Annual revenue (last year)$214.2M
Annual profit (last year)-$39.0M
Net profit margin-18.20%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer, Secretary &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts